Alto Neuroscience Inc. share price logo

Alto Neuroscience Inc.

NASDAQ: ANRO

Small Cap

$21.79

+0.79

(+3.76%)

as on

Alto Neuroscience Inc. Stock Performance

as on June 18, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $21.02
    $22.28
    downward going graph

    3.53%

    Downside

    2.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.15
    $28.44
    downward going graph

    90.13%

    Downside

    30.52%

    Upside

    downward going graph

Alto Neuroscience Inc. share price movements today

Previous Close
$21.00
Open
$21.64
Volume
211.3K
Day's Low - High
$21.02 - $22.28
52 Week Low - High
$2.15 - $28.44

Alto Neuroscience Inc. Historical Returns

1 Month Return
-0.05 %
3 Month Return
-3.24 %
1 Year Return
+ 859.91 %
3 Year Return
0 %
5 Year Return
0 %

Alto Neuroscience Inc. Stock Fundamentals & Key Indicators

Check Alto Neuroscience Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$742.9M

EPS (TTM)

-2.2489

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-77.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-38.86%

Alto Neuroscience Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alto Neuroscience Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Alto Neuroscience Inc. image
Alto Neuroscience Inc.
BUY$742.9MNANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.6B59.83%71.0112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$115.0B144.34%26.8835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$64.4B13.01%15.0229.65%0.58%

Stock Returns calculator for Alto Neuroscience Inc. Stock including INR - Dollar returns

The Alto Neuroscience Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Alto Neuroscience Inc. investment value today

Current value as on today

₹10,48,939

Returns

₹9,48,939

(+948.94%)

Returns from Alto Neuroscience Inc. Stock

₹8,59,912 (+859.91%)

Dollar Impact

₹89,027 (+89.03%)

Analyst Recommendation on Alto Neuroscience Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Alto Neuroscience Inc.. Average target price of $35.13

Alto Neuroscience Inc. Share Price Target

Get share price movements and forecasts by analysts on Alto Neuroscience Inc..

What analysts predicted

37.97%UPSIDE

Target Price

$35.13

Current Price

$21.79

Analyzed by

11 Analysts

Target

$35.13

Alto Neuroscience Inc. target price $35.13, a slight upside of 37.97% compared to current price of $21.79. According to 11 analysts rating.

Indian Investors' Interest in Alto Neuroscience Inc. Stock

Search interest for Alto Neuroscience Inc. Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:16% versus previous 30 day period

Alto Neuroscience Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
-
-
0
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-11
-14
-18
-18
-16
-15
-18
-14
115
-27
EBITDA
-10
-12
-15
-16
-14
-14
-16
-13
-15
-25
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-13
-16
-16
-15
-15
-17
-14
-16
-26
Income Tax Expense
0
-
0
-
-
-
-
-
-
-
Net Income
-11
-13
-16
-16
-15
-15
-17
-14
-16
-26
Net Profit Margin
-3015.32%
0.00%
0.00%
0.00%
-3858.12%
0.00%
0.00%
0.00%
0.00%
0.00%

Alto Neuroscience Inc. Annual Profit & Loss

All numbers in Millions USD

Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
0
-
-
-
-
Gross Profit
0
0
0
0
0
Operating Income
-12
-29
-37
-68
-66
EBITDA
-9
-27
-34
-68
-60
Interest Expense
-
-
1
1
2
Depreciation
0
0
0
0
0
Income Before Tax
-9
-27
-36
-61
-63
Income Tax Expense
-
-
-
-61
-
Net Income
-9
-27
-36
-61
-63
Net Profit Margin
-4374.76%
0.00%
0.00%
0.00%
0.00%

Alto Neuroscience Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-13
-16
-16
-15
-15
-17
-14
-16
-26
Operating Cash Flow
-10
-11
-11
-13
-16
-13
-9
-11
-27
Investing Cash Flow
0
0
-1
0
0
-
-
-
0
Financing Cash Flow
134
0
1
0
9
0
0
50
114
Change in Cash
123
-12
-11
-13
-7
-13
-9
38
87

Alto Neuroscience Inc. Annual Cash Flow

All numbers in Millions USD

Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
-27
-36
-61
-63
Operating Cash Flow
-20
-33
-47
-51
Investing Cash Flow
0
0
-2
0
Financing Cash Flow
43
68
135
60
Change in Cash
22
34
86
8

Global Institutional Holdings in Alto Neuroscience Inc.

Funds
Holdings
Alpha Wave Global LP
10.57%
Affinity Asset Advisors, LLC
1.42%
Driehaus Capital Management LLC
1.39%
BlackRock Inc
1.9%
Adage Capital Partners Gp LLC
1.21%
See all

Alto Neuroscience Inc. News & Key Events

  • img

    Today's Timeline - 13 January

    Tue, 07:21 PM

    -

    Alto Neuroscience presents new data validating Theta-ITC as a key EEG biomarker at the ACNP annual meeting.

Insights on Alto Neuroscience Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ANRO stock has moved up by 859.9%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ANRO has outperformed top 5 stocks with highest market-cap in its industry

About Alto Neuroscience Inc.

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD; and ALTO-208, a fixed-dose combination of pramipexole and aprepitant, an antiemetic, neurokinin-1 (NK-1) receptor antagonist for patients with Parkinson's disease for patients with Parkinson's disease. The company was incorporated in 2019 and is headquartered in Mountain View, California.
OrganisationAlto Neuroscience Inc.
Headquarters650 Castro Street, Mountain View, CA, United States, 94041
IndustryBiotechnology
CEODr. Amit Etkin M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Alto Neuroscience Inc.

Name

Title

Mr. Michael C. Hanley M.B.A.

Chief Operating Officer

Mr. Dan Segal B.Sc. (Hons), BCom, CA, MSc

Co-Founder & Strategic Advisor

Ms. Erin R. McQuade J.D.

General Counsel, Chief Administrative Officer & Corporate Secretary

Mr. Adam Savitz M.D., Ph.D.

Chief Medical Officer

Ms. Jessica Powell

Chief Development Officer

Dr. Amit Etkin M.D., Ph.D.

Founder, Chairman of the Board, CEO & President

Mr. Nicholas C. Smith

CFO & Chief Business Officer

FAQs

What is Alto Neuroscience Inc. share price today?

Alto Neuroscience Inc. share price today is $21.79 as on at the close of the market. Alto Neuroscience Inc. share today touched a day high of $22.28 and a low of $21.02.

What is the 52 week high and 52 week low for Alto Neuroscience Inc. share?

Alto Neuroscience Inc. share touched a 52 week high of $28.44 on and a 52 week low of $2.15 on . Alto Neuroscience Inc. stock price today i.e. is closed at $21.79,which is 23.39% down from its 52 week high and 913.49% up from its 52 week low.

What is Alto Neuroscience Inc.'s market capitalisation today?

Alto Neuroscience Inc. market capitalisation is $0.00T as on .

How to invest in Alto Neuroscience Inc. Stock (ANRO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alto Neuroscience Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alto Neuroscience Inc. Shares that will get you 0.0688 shares as per Alto Neuroscience Inc. share price of $21.79 per share as on June 18, 2026 at 8:45 am IST.

What is the minimum amount required to buy Alto Neuroscience Inc. Stock (ANRO) from India?

Indian investors can start investing in Alto Neuroscience Inc. (ANRO) shares with as little as ₹94.323 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in Alto Neuroscience Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Alto Neuroscience Inc. share’s latest price of $21.79 as on June 18, 2026 at 8:45 am IST, you will get 0.4589 shares of Alto Neuroscience Inc.. Learn more about fractional shares .